{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:19:46Z","timestamp":1778588386406,"version":"3.51.4"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Lymph node (LN) metastasis constitutes a major adverse prognostic factor in surgically treated cervical cancer (CC) patients. Leveraging the Surveillance, Epidemiology, and End Results database, this study aimed to evaluate the prognostic value of the number of positive LN metastases (nLNM) and LN ratio (LNR) in patients with stage IB-IIA CC who underwent surgical treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective analysis was conducted on patients with histopathologically confirmed CC between 2010 and 2021, with overall survival (OS) as the primary endpoint. nLNM stratification was performed using X-title software, followed by Kaplan\u2013Meier (K-M) analysis. For LNR, restricted cubic spline (RCS) analysis identified inflection points between the number of examined regional LNs and OS. Subsequently, X-title software and K-M analysis independently compared OS between the negative and positive LN(s) groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 100\u00a0097 LNs from 5911 CC patients were analyzed. Among these, 856 (14.48%) patients had positive LNs. The presence of positive LNs was associated with a significantly lower 10-year OS rate compared to those with negative LNs (69.0% vs. 86.7%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). The nLNM stratification, generated using X-title software and K-M analysis, exhibited the highest discriminatory power with categories of negative vs. 1\u20133\u00a0+\u00a0vs.\u00a0\u22654+\u00a0LNs metastasis (all\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). RCS analysis revealed a nadir at 15 examined LNs and indicated excluding patients with fewer than 8 LNs examined during surgery. No OS difference was observed between patients with 9\u201315 LNs and those with \u226516 LNs examined when LNR\u00a0=\u00a00 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.365). However, an LNR \u22650.210 was associated with significantly poorer OS (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Extensive pelvic lymphadenectomy provided no survival benefit for patients with \u226516 examined, pathologically negative LNs compared to those with 9\u201315 LNs examined. Both nLNM \u22654+\u00a0and LNR \u22650.210 were identified as significant prognostic factors, offering valuable insights for clinical decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003033","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T08:00:15Z","timestamp":1753689615000},"page":"8141-8148","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Unraveling the prognostic puzzle: an in-depth exploration of lymph node metrics in surgically treated FIGO stage IB-IIA cervical cancer \u2013 A retrospective cohort study focused on the number of positive lymph nodes and the lymph node ratio"],"prefix":"10.1097","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5579-7115","authenticated-orcid":false,"given":"Tao","family":"Song","sequence":"first","affiliation":[{"name":"Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People\u2019s Hospital, Affiliated People\u2019s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Zhejiang Provincial People\u2019s Hospital, Affiliated People\u2019s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangjie","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Outpatient Nursing, Zhejiang Provincial People\u2019s Hospital, Affiliated People\u2019s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyan","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Gynecologic Oncology, Jiangxi Cancer Hospital, Nanchang, Jiangxi, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixuan","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Mathematics, Changsha University, Changsha, Hunan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Physics, Hangzhou Normal University, Hangzhou, Zhejiang, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huafeng","family":"Shou","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Zhejiang Provincial People\u2019s Hospital, Affiliated People\u2019s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1756-100X","authenticated-orcid":false,"given":"Hong\u2019en","family":"Xu","sequence":"additional","affiliation":[{"name":"Cancer Center, Department of Radiation Oncology, Zhejiang Provincial People\u2019s Hospital, Affiliated People\u2019s Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"R1-20260512","first-page":"28\u201344","article-title":"Cancer of the cervix uteri: 2021 update","volume":"155 Suppl 1","author":"Bhatla","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"R2-20260512","first-page":"229\u201363","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R3-20260512","first-page":"47\u201353","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J Natl Cancer Cent"},{"key":"R4-20260512","doi-asserted-by":"crossref","first-page":"216\u201324","DOI":"10.1136\/ijgc-2021-002527","article-title":"Management of stage I and II cervical cancer: a review","volume":"32","author":"Chou","year":"2022","journal-title":"Int J Gynecol Cancer"},{"key":"R5-20260512","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.3390\/cancers16142541","article-title":"Management for cervical cancer patients: a comparison of the guidelines from the international scientific societies (ESGO-NCCN-ASCO-AIOM-FIGO-BGCS-SEOM-ESMO-JSGO)","volume":"16","author":"Restaino","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R6-20260512","doi-asserted-by":"crossref","first-page":"423\u201328","DOI":"10.1016\/j.ygyno.2020.02.031","article-title":"Significance of the number of high-risk factors in patients with cervical cancer treated with radical hysterectomy and concurrent chemoradiotherapy","volume":"157","author":"Kim","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R7-20260512","doi-asserted-by":"crossref","first-page":"129\u201335","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"R8-20260512","doi-asserted-by":"crossref","first-page":"333\u201344","DOI":"10.2147\/IJWH.S348074","article-title":"Prognostic analysis and comparison of the 2014 and 2018 international federation of gynecology and obstetrics staging system on overall survival in patients with stage IIB-IVA cervix carcinoma","volume":"14","author":"Song","year":"2022","journal-title":"Int J Womens Health"},{"key":"R9-20260512","doi-asserted-by":"crossref","first-page":"959\u201368","DOI":"10.1002\/ijgo.15218","article-title":"Survival outcomes of 2018 FIGO stage IIIC versus stages IIIA and IIIB in cervical cancer: a systematic review with meta-analysis","volume":"165","author":"Zhang","year":"2024","journal-title":"Int J Gynaecol Obstet"},{"key":"R10-20260512","doi-asserted-by":"crossref","first-page":"85\u201392","DOI":"10.1016\/j.ygyno.2019.10.025","article-title":"The variable impact of positive lymph nodes in cervical cancer: implications of the new FIGO staging system","volume":"156","author":"McComas","year":"2020","journal-title":"Gynecol Oncol"},{"key":"R11-20260512","doi-asserted-by":"crossref","first-page":"873\u201378","DOI":"10.1136\/ijgc-2020-001257","article-title":"Revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging: a review of gaps and questions that remain","volume":"30","author":"Salvo","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"R12-20260512","doi-asserted-by":"crossref","first-page":"550\u201357","DOI":"10.1111\/aogs.14316","article-title":"The prognostic value of the number of positive lymph nodes and the lymph node ratio in early-stage cervical cancer","volume":"101","author":"Olthof","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R13-20260512","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1186\/s12885-024-12784-8","article-title":"Predictive value of number of metastatic lymph nodes and lymph node ratio for prognosis of patients with FIGO 2018 stage IIICp cervical cancer: a multi-center retrospective study","volume":"24","author":"Ye","year":"2024","journal-title":"BMC Cancer"},{"key":"R14-20260512","doi-asserted-by":"crossref","first-page":"588\u201389","DOI":"10.1001\/jamasurg.2018.0501","article-title":"Practical guide to surgical data sets: Surveillance, Epidemiology, and End Results (SEER) database","volume":"153","author":"Doll","year":"2018","journal-title":"JAMA Surg"},{"key":"R15-20260512","doi-asserted-by":"crossref","first-page":"110\u201317","DOI":"10.1093\/jncimonographs\/lgae022","article-title":"The SEER Program\u2019s evolution: supporting clinically meaningful population-level research","volume":"2024","author":"Penberthy","year":"2024","journal-title":"J Natl Cancer Inst Monogr"},{"key":"R16-20260512","first-page":"50","article-title":"How to use the Surveillance, Epidemiology, and End Results (SEER) data: research design and methodology","volume":"10","author":"Che","year":"2023","journal-title":"Mil Med Res"},{"key":"R17-20260512","doi-asserted-by":"crossref","first-page":"504\u201309","DOI":"10.1136\/ijgc-2023-005151","article-title":"Consensus on surgical technique for sentinel lymph node dissection in cervical cancer","volume":"34","author":"Bizzarri","year":"2024","journal-title":"Int J Gynecol Cancer"},{"key":"R18-20260512","first-page":"256\u201369","article-title":"National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version)","volume":"34","year":"2022","journal-title":"Chin J Cancer Res"},{"key":"R19-20260512","first-page":"100081","article-title":"Revised Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) guideline: an update for the age of artificial intelligence","volume":"10","author":"Agha","year":"2025","journal-title":"Premier J Sci"},{"key":"R20-20260512","doi-asserted-by":"crossref","first-page":"1277\u201380","DOI":"10.1200\/JCO.2013.53.8009","article-title":"American society of clinical oncology perspective: raising the bar for clinical trials by defining clinically meaningful outcomes","volume":"32","author":"Ellis","year":"2014","journal-title":"J Clin Oncol"},{"key":"R21-20260512","doi-asserted-by":"crossref","first-page":"385\u201388","DOI":"10.1016\/j.ejca.2011.10.028","article-title":"Poor correlation between progression-free and overall survival in modern clinical trials: are composite endpoints the answer?","volume":"48","author":"Amir","year":"2012","journal-title":"Eur J Cancer"},{"key":"R22-20260512","doi-asserted-by":"crossref","first-page":"6867\u201376","DOI":"10.1002\/cam4.5477","article-title":"A 5-year survival status prognosis of nonmetastatic cervical cancer patients through machine learning algorithms","volume":"12","author":"Yu","year":"2023","journal-title":"Cancer Med"},{"key":"R23-20260512","doi-asserted-by":"crossref","first-page":"7252\u201359","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R24-20260512","first-page":"26057\u201365","article-title":"Incorporation of the number of positive lymph nodes leads to better prognostic discrimination of node-positive early stage cervical cancer","volume":"8","author":"Zhou","year":"2017","journal-title":"Oncotarget"},{"key":"R25-20260512","doi-asserted-by":"crossref","first-page":"1224\u201333","DOI":"10.6004\/jnccn.2023.0062","article-title":"NCCN Guidelines(R) insights: cervical cancer, version 1.2024","volume":"21","author":"Abu-Rustum","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"R26-20260512","doi-asserted-by":"crossref","first-page":"16\u201320","DOI":"10.1016\/j.ygyno.2016.08.337","article-title":"Can sentinel lymph node biopsy replace pelvic lymphadenectomy for early cervical cancer?","volume":"144","author":"Lennox","year":"2017","journal-title":"Gynecol Oncol"},{"key":"R27-20260512","doi-asserted-by":"crossref","first-page":"1136\u201338","DOI":"10.1111\/j.1525-1438.2007.01138.x","article-title":"Classification of radical hysterectomy adopted by the gynecological cancer group of the European organization for research and treatment of cancer","volume":"18","author":"Mota","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R28-20260512","doi-asserted-by":"crossref","first-page":"331\u201337","DOI":"10.1016\/j.ejso.2020.06.014","article-title":"Utility of the 3-tier grouping system for survival discriminatory ability in stage IIA cervical cancer","volume":"47","author":"Matsuo","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"R29-20260512","doi-asserted-by":"crossref","first-page":"347\u201352","DOI":"10.1016\/j.ygyno.2010.12.334","article-title":"Sentinel lymph node biopsy in the management of early-stage cervical carcinoma","volume":"120","author":"Diaz","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R30-20260512","doi-asserted-by":"crossref","first-page":"307\u201315","DOI":"10.1016\/j.ejca.2021.02.009","article-title":"Sentinel lymph node biopsy and morbidity outcomes in early cervical cancer: results of a multicentre randomised trial (SENTICOL-2)","volume":"148","author":"Mathevet","year":"2021","journal-title":"Eur J Cancer"},{"key":"R31-20260512","doi-asserted-by":"crossref","first-page":"1686\u201391","DOI":"10.1200\/JCO.2010.32.0432","article-title":"Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study","volume":"29","author":"Lecuru","year":"2011","journal-title":"J Clin Oncol"},{"key":"R32-20260512","doi-asserted-by":"crossref","first-page":"1\u201320","DOI":"10.1016\/j.ejso.2014.09.010","article-title":"Sentinel node biopsy for lymph nodal staging of uterine cervix cancer: a systematic review and meta-analysis of the pertinent literature","volume":"41","author":"Kadkhodayan","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"R33-20260512","doi-asserted-by":"crossref","first-page":"56\u201371","DOI":"10.1056\/NEJMra2404457","article-title":"Cervical cancer","volume":"392","author":"Tewari","year":"2025","journal-title":"N Engl J Med"},{"key":"R34-20260512","doi-asserted-by":"crossref","first-page":"182\u201399","DOI":"10.1038\/s41571-024-00977-w","article-title":"Treatment advances across the cervical cancer spectrum","volume":"22","author":"Francoeur","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"R35-20260512","doi-asserted-by":"crossref","first-page":"e27035","DOI":"10.1097\/MD.0000000000027035","article-title":"Sentinel lymph node mapping in early-stage cervical cancer: meta-analysis","volume":"100","author":"Wang","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"R36-20260512","doi-asserted-by":"crossref","first-page":"994105","DOI":"10.3389\/fonc.2022.994105","article-title":"Impact of examined lymph node number on lymph node status and prognosis in FIGO stage IB-IIA cervical squamous cell carcinoma: a population-based study","volume":"12","author":"Yong","year":"2022","journal-title":"Front Oncol"},{"key":"R37-20260512","doi-asserted-by":"crossref","first-page":"240\u201346","DOI":"10.1016\/j.ygyno.2016.02.011","article-title":"A phase II study of postoperative concurrent carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy followed by consolidation chemotherapy in surgically treated cervical cancer patients with positive pelvic lymph nodes","volume":"141","author":"Mabuchi","year":"2016","journal-title":"Gynecol Oncol"},{"key":"R38-20260512","doi-asserted-by":"crossref","first-page":"602\u201306","DOI":"10.1136\/ijgc-2019-000690","article-title":"Consolidation chemotherapy in early-stage cervical cancer patients with lymph node metastasis after radical hysterectomy","volume":"30","author":"Zhong","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"R39-20260512","doi-asserted-by":"crossref","first-page":"122\u201329","DOI":"10.1093\/jjco\/hyac170","article-title":"The effectiveness of consolidation chemotherapy in high-risk early-stage cervical cancer patients following concurrent chemoradiation after radical surgery","volume":"53","author":"Wang","year":"2023","journal-title":"Jpn J Clin Oncol"},{"key":"R40-20260512","doi-asserted-by":"crossref","first-page":"412\u201317","DOI":"10.1016\/j.clon.2005.02.006","article-title":"Preliminary results of consolidation chemotherapy following concurrent chemoradiation after radical surgery in high-risk early-stage carcinoma of the uterine cervix","volume":"17","author":"Lee","year":"2005","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"R41-20260512","doi-asserted-by":"crossref","first-page":"97\u2013103","DOI":"10.4143\/crt.2012.44.2.97","article-title":"Phase II study of consolidation chemotherapy after adjuvant or primary concurrent chemoradiation using paclitaxel and carboplatin to treat high-risk early-stage or locally advanced cervical cancer","volume":"44","author":"Kim","year":"2012","journal-title":"Cancer Res Treat"},{"key":"R42-20260512","doi-asserted-by":"crossref","first-page":"659\u201367","DOI":"10.1016\/j.jogc.2017.02.017","article-title":"Implementing a cervical sentinel lymph node biopsy program: quality improvement in gynaecologic oncology","volume":"39","author":"Cusimano","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"R43-20260512","doi-asserted-by":"crossref","first-page":"151\u201356","DOI":"10.1016\/j.ygyno.2022.11.017","article-title":"Stratification of lymph node metastases as macrometastases, micrometastases, or isolated tumor cells has no clinical implication in patients with cervical cancer: subgroup analysis of the SCCAN project","volume":"168","author":"Dostalek","year":"2023","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:03:21Z","timestamp":1778587401000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":43,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003033","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"2025-02-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}